je.st
news
Home
› Rxi Pharmaceuticals: One Undervalued Biotech That Keeps Building Its Pipeline For Future Value
Rxi Pharmaceuticals: One Undervalued Biotech That Keeps Building Its Pipeline For Future Value
2015-05-02 15:52:22| Biotech - Topix.net
Multiple collaborations between the sd-rxRNA technology and other biotech platforms provide reduced future risk along with validation of the platform. Further positive results in scarring allow the possibility to branch into other skin areas such as Pulmonary Fibrosis and Liver Fibrosis both of which are huge markets.
Tags: future
value
building
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||